LADENBURG THALMANN FINANCIAL SERVICES INC. - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 404 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2016. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$237,0000.0%14,9490.0%0.00%0.0%
Q1 2018$237,000
-21.5%
14,949
+2.5%
0.00%
-33.3%
Q4 2017$302,000
+64.1%
14,583
+13.7%
0.00%
+50.0%
Q3 2017$184,000
-46.8%
12,824
-35.9%
0.00%
-50.0%
Q2 2017$346,000
+21.4%
20,008
-22.8%
0.00%0.0%
Q1 2017$285,000
-23.0%
25,908
+3.4%
0.00%
-20.0%
Q4 2016$370,000
-24.2%
25,055
+26.4%
0.01%
-28.6%
Q3 2016$488,000
+19.3%
19,825
-2.0%
0.01%0.0%
Q2 2016$409,000
+6.0%
20,226
+41.1%
0.01%0.0%
Q1 2016$386,000
-66.4%
14,336
+26.1%
0.01%
-66.7%
Q4 2015$1,149,000
-47.1%
11,367
-6.6%
0.02%
-53.3%
Q3 2015$2,172,000
-4.1%
12,174
+19.7%
0.04%
+7.1%
Q2 2015$2,266,000
+23.4%
10,170
+9.9%
0.04%
+20.0%
Q1 2015$1,837,000
+71.4%
9,256
+27.1%
0.04%
+45.8%
Q4 2014$1,072,000
+71.2%
7,284
+52.5%
0.02%
+41.2%
Q3 2014$626,000
-7.0%
4,775
-10.5%
0.02%
-5.6%
Q2 2014$673,000
-70.2%
5,334
-68.9%
0.02%
-72.7%
Q1 2014$2,259,000
-20.0%
17,130
-29.0%
0.07%
-24.1%
Q4 2013$2,825,000
+13.5%
24,123
+1.2%
0.09%
+3.6%
Q3 2013$2,490,000
+32.5%
23,847
+9.8%
0.08%
+25.4%
Q2 2013$1,879,00021,7150.07%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q1 2016
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,106,379$55,398,00031.67%
Claren Road Asset Management, LLC 80,000$2,820,00024.27%
Okumus Fund Management Ltd. 3,722,464$97,901,00015.82%
Wingspan Investment Management, LP 852,900$22,431,00012.66%
FARLEY CAPITAL L.P. 307,458$8,086,00011.46%
Chou Associates Management 976,843$25,725,0008.35%
Wingspan Investment Management, LP 550,700$14,483,0008.17%
HAP Trading, LLC 4,043,900$109,610,0008.00%
LeVasseur Capital Partners LLC 128,269$3,373,0006.97%
Pershing Square Capital Management 21,591,122$567,847,0006.41%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders